Clinical Trials
2 trialsNCT05411718 2026-06-01
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02052908 2021-01-25
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
National Cancer Institute (NCI)
Phase 1 Completed